» Articles » PMID: 35864124

A Simplified Prediction Model for End-stage Kidney Disease in Patients with Diabetes

Abstract

This study aimed to develop a simplified model for predicting end-stage kidney disease (ESKD) in patients with diabetes. The cohort included 2549 individuals who were followed up at Kyushu University Hospital (Japan) between January 1, 2008 and December 31, 2018. The outcome was a composite of ESKD, defined as an eGFR < 15 mL min [1.73 m], dialysis, or renal transplantation. The mean follow-up was 5.6 [Formula: see text] 3.7 years, and ESKD occurred in 176 (6.2%) individuals. Both a machine learning random forest model and a Cox proportional hazard model selected eGFR, proteinuria, hemoglobin A1c, serum albumin levels, and serum bilirubin levels in a descending order as the most important predictors among 20 baseline variables. A model using eGFR, proteinuria and hemoglobin A1c showed a relatively good performance in discrimination (C-statistic: 0.842) and calibration (Nam and D'Agostino [Formula: see text] statistic: 22.4). Adding serum albumin and bilirubin levels to the model further improved it, and a model using 5 variables showed the best performance in the predictive ability (C-statistic: 0.895, [Formula: see text] statistic: 7.7). The accuracy of this model was validated in an external cohort (n = 5153). This novel simplified prediction model may be clinically useful for predicting ESKD in patients with diabetes.

Citing Articles

Dynamic survival prediction of end-stage kidney disease using random survival forests for competing risk analysis.

Christiadi D, Chai K, Chuah A, Loong B, Andrews T, Chakera A Front Med (Lausanne). 2024; 11:1428073.

PMID: 39722823 PMC: 11668785. DOI: 10.3389/fmed.2024.1428073.


Machine Learning Models for Prediction of Diabetic Microvascular Complications.

Kanbour S, Harris C, Lalani B, Wolf R, Fitipaldi H, Gomez M J Diabetes Sci Technol. 2024; 18(2):273-286.

PMID: 38189280 PMC: 10973856. DOI: 10.1177/19322968231223726.

References
1.
. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019; . DOI: 10.1053/j.ajkd.2019.09.002. View

2.
Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N . Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol. 2003; 14(8 Suppl 3):S227-32. DOI: 10.1097/01.asn.0000077407.90309.65. View

3.
Inoguchi T, Sasaki S, Kobayashi K, Takayanagi R, Yamada T . Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA. 2007; 298(12):1398-400. DOI: 10.1001/jama.298.12.1398-b. View

4.
Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M . Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study. Atherosclerosis. 2018; 279:38-44. DOI: 10.1016/j.atherosclerosis.2018.10.014. View

5.
Riley R, Ensor J, Snell K, Debray T, Altman D, Moons K . External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ. 2016; 353:i3140. PMC: 4916924. DOI: 10.1136/bmj.i3140. View